These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 6771801)
1. Subacute L-DOPA in mice: biochemical and behavioural effects. Jenkins O; Bailey R; Crisp E; Jackson DM Psychopharmacology (Berl); 1980; 68(1):77-83. PubMed ID: 6771801 [TBL] [Abstract][Full Text] [Related]
2. Chronic L-DOPA treatment of mice: a behavioural and biochemical study. Bailey R; Crisp E; Jackson DM; Jenkins O J Neural Transm; 1981; 50(2-4):209-24. PubMed ID: 6787171 [TBL] [Abstract][Full Text] [Related]
3. Chronic L-dopa treatment of rats and mice does not change the sensitivity of post-synaptic dopamine receptors. Jackson DM; Jenkins OF; Malor R; Christie MJ; Gregory P Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec; 324(4):271-4. PubMed ID: 6686648 [TBL] [Abstract][Full Text] [Related]
4. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites. Alachkar A; Brotchie JM; Jones OT Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064 [TBL] [Abstract][Full Text] [Related]
5. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats. Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859 [TBL] [Abstract][Full Text] [Related]
6. Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primate. Barnes JC; Barnes NJ; Barnes NM; Costall B; Domeney AM; Naylor RJ Neuropharmacology; 1987 Jul; 26(7A):693-700. PubMed ID: 3114665 [TBL] [Abstract][Full Text] [Related]
7. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia. Jackson DM; Walters JR; Miller LP Brain Res; 1982 Nov; 250(2):271-82. PubMed ID: 6129029 [TBL] [Abstract][Full Text] [Related]
8. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306 [TBL] [Abstract][Full Text] [Related]
9. Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice. Jenkins OF; Jackson DM Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):7-11. PubMed ID: 3877878 [TBL] [Abstract][Full Text] [Related]
10. Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration. Fredriksson A; Archer T Behav Brain Res; 2003 Feb; 139(1-2):31-46. PubMed ID: 12642174 [TBL] [Abstract][Full Text] [Related]
11. The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice. Tabar J; Hashizume M; Cook CJ; Beart PM; Jackson DM Pharmacol Biochem Behav; 1989 May; 33(1):139-46. PubMed ID: 2789405 [TBL] [Abstract][Full Text] [Related]
12. Behavioural and biochemical changes following chronic administration of L-dopa to rats. Pycock C; Dawbarn D; O'Shaughnessy C Eur J Pharmacol; 1982 Apr; 79(3-4):201-15. PubMed ID: 7201400 [TBL] [Abstract][Full Text] [Related]
13. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar. Huang L; Deng M; Zhang S; Fang Y; Li L Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244 [TBL] [Abstract][Full Text] [Related]
14. [Central action of beta-phenylethylamine derivatives (10). Effect of L-Dopa on metaraminol induced motor activity (author's transl)]. Shoji T; Tadano T; Kisara K Nihon Yakurigaku Zasshi; 1977 May; 73(4):371-8. PubMed ID: 908541 [TBL] [Abstract][Full Text] [Related]
15. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. Eskow KL; Gupta V; Alam S; Park JY; Bishop C Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556 [TBL] [Abstract][Full Text] [Related]
16. L-dopa and apomorphine disrupt long- but not short-behavioural chains. Schmidt WJ Physiol Behav; 1984 Nov; 33(5):671-80. PubMed ID: 6522487 [TBL] [Abstract][Full Text] [Related]
17. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity. Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702 [TBL] [Abstract][Full Text] [Related]
18. Impaired behavioural and molecular adaptations to dopamine denervation and repeated L-DOPA treatment in Nur77-knockout mice. St-Hilaire M; Bourhis E; Lévesque D; Rouillard C Eur J Neurosci; 2006 Aug; 24(3):795-805. PubMed ID: 16930409 [TBL] [Abstract][Full Text] [Related]
19. [Effect of L-dihydroxyphenylalanine on rat behavior and on catecholamine metabolism of the brain in rats with different degrees of emotional-behavioral reactivity]. Bondarenko NA; Miroshnichenko II; Kudrin VS; Bondarenko NA Biull Eksp Biol Med; 1988 Aug; 106(8):168-70. PubMed ID: 3416051 [TBL] [Abstract][Full Text] [Related]
20. Some behavioural effects of chloroquine in rats suggesting dopaminergic activation. Amabeoku GJ Indian J Med Res; 1994 Feb; 99():87-94. PubMed ID: 8005645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]